Latest News & Features
Biotechnology
Controversial patents covering a fruit and a vegetable are awaiting their fate at the Enlarged Board of Appeal. LSIPR examines the likelihood of their succeeding. 3 March 2015
Americas
Which patented drugs are losing their market exclusivity in 2015, and how will their makers cope? LSIPR takes a look at five of the biggest drugs to lose patent protection in the US this year. 3 March 2015
Americas
Professional services firm CohnReznick has expanded its technology and life sciences industry practice group to Austin, Texas. 26 February 2015
Americas
Swiss pharmaceutical company Novartis can buy London-based GlaxoSmithKline’s portfolio of cancer drugs after it agreed to meet certain conditions set by the US Federal Trade Commission, the agency has said. 24 February 2015
Americas
Pharmaceutical companies Teva, Momenta, Mylan and Sandoz have asked the US Court of Appeals for the Federal Circuit for an expedited ruling on the validity of Teva’s patent covering its Copaxone drug. 23 February 2015
Americas
Molecular diagnostic company Myriad Genetics has settled the last of its seven BRCA-related patent disputes in the US, this time with genetic testing company GeneDx. 20 February 2015
Big Pharma
The Court of Justice of the European Union has clarified when pharmaceutical patent owners may rely on the Specific Mechanism to prevent parallel imports of their products. 19 February 2015
Big Pharma
The tussle between Teva and Amgen over the latter’s SPC for lipegfilgrastim is still playing out in Denmark’s IP court and may yet be referred to the CJEU. Michael Pitzner-Bruun of law firm Kromann Reumert reports. 19 February 2015
article
Two years after its launch, the LSIPR monthly is having a re-brand. This issue will be the final one published in a PDF format, as in March we are switching to a ‘digital first’ strategy. 19 February 2015
Americas
As Myriad seems to have thrown in the towel in its fight to protect patents covering its BRCA diagnostic tests, LSIPR asks whether the gene patent’s days are numbered in the US, and takes a look at its fortunes in other jurisdictions. 19 February 2015